.Ascendis Pharma has emerged as a possible hazard to BioMarin's Voxzogo, reporting period 3 developm...
.Though Alkeus Pharmaceuticals' dental eye illness property fell short to significantly decrease geo...
.Along with a triad of biotechs hitting the Nasdaq on Friday, it was actually effortless to overlook...
.Invulnerable checkpoint inhibitors are actually the superheroes of cancer therapy. Medications like...
.Accept to recently's Chutes & Ladders, our roundup of significant management hirings, firings as...
.Regeneron is back with long-term follow-up for its own LAG-3 prevention and PD-1 inhibitor combo in...
.AstraZeneca has discussed a very early examine the efficiency of its internal antibody-drug conjuga...
.After declaring a period 3 launch based upon good midstage results, iTeos and GSK are lastly sharin...
.The FDA should be even more open as well as collaborative to let loose a surge in approvals of unus...
.It's an extraordinarily occupied Friday for biotech IPOs, along with Zenas BioPharma, MBX and also ...